Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Tron Pharmaceuticals stock

TGRP
US8970121005
A2QL98

Price

0.04
Today +/-
+0.01
Today %
+43.61 %
P

Tron Pharmaceuticals stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Tron Pharmaceuticals stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Tron Pharmaceuticals stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Tron Pharmaceuticals stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Tron Pharmaceuticals's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Tron Pharmaceuticals Stock Price History

DateTron Pharmaceuticals Price
11/13/20240.04 undefined
11/12/20240.02 undefined
11/11/20240.03 undefined
11/7/20240.02 undefined
11/6/20240.03 undefined
11/5/20240.03 undefined
11/4/20240.02 undefined
11/1/20240.03 undefined
10/31/20240.04 undefined
10/30/20240.04 undefined
10/29/20240.04 undefined
10/28/20240.04 undefined
10/25/20240.03 undefined
10/24/20240.05 undefined
10/23/20240.06 undefined
10/22/20240.06 undefined
10/21/20240.06 undefined
10/18/20240.08 undefined

Tron Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Tron Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Tron Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Tron Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Tron Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Tron Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Tron Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Tron Pharmaceuticals’s growth potential.

Tron Pharmaceuticals Revenue, EBIT and net profit per share

DateTron Pharmaceuticals RevenueTron Pharmaceuticals EBITTron Pharmaceuticals Net Income
20171.48 M undefined-1.23 M undefined-800,000 undefined
20161.48 M undefined-910,000 undefined-580,000 undefined

Tron Pharmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (k)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20162017
1,0001,000
--
--
00
00
--
163.33163.33
--
Details

Keystats

ⓘ

Revenue and Growth

The Tron Pharmaceuticals Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Tron Pharmaceuticals is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (k)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (k)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (k)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (k)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (k)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (k)DEBT (M)TOTAL CAPITAL (M)
20162017
   
350100
19090
00
180160
34050
1.060.4
330260
00
00
00
00
00
330260
1.390.66
   
0160
2.862.7
-11.05-11.88
1.450.94
00
-6.74-8.08
300310
90110
7.919.18
00
2020
8.329.62
2010
00
00
2010
8.349.63
1.61.55
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Tron Pharmaceuticals provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Tron Pharmaceuticals's financial health and stability.

Assets

Tron Pharmaceuticals's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Tron Pharmaceuticals must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Tron Pharmaceuticals after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Tron Pharmaceuticals's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (k)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20162017
0-1
00
00
00
00
00
00
00
00
00
00
00
00
00
01,000
01,000
00
00
-0.89-0.52
00

Tron Pharmaceuticals stock margins

The Tron Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tron Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tron Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Tron Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Tron Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Tron Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Tron Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Tron Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Tron Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Tron Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Tron Pharmaceuticals Margin History

Tron Pharmaceuticals Gross marginTron Pharmaceuticals Profit marginTron Pharmaceuticals EBIT marginTron Pharmaceuticals Profit margin
201728.38 %-83.11 %-54.05 %
201646.62 %-61.49 %-39.19 %

Tron Pharmaceuticals Stock Sales Revenue, EBIT, Earnings per Share

The Tron Pharmaceuticals earnings per share therefore indicates how much revenue Tron Pharmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Tron Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Tron Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Tron Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Tron Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Tron Pharmaceuticals Revenue, EBIT and net profit per share

DateTron Pharmaceuticals Sales per ShareTron Pharmaceuticals EBIT per shareTron Pharmaceuticals Earnings per Share
20170.01 undefined-0.01 undefined-0 undefined
20160.01 undefined-0.01 undefined-0 undefined

Tron Pharmaceuticals business model

The Tron Group Inc is a leading company specializing in the development and production of innovative products in various industries. It was founded in 1992 and is headquartered in New York City, with many branches worldwide. The beginnings of Tron Group Inc are in the LED lighting industry. As a pioneer in this field, the company has developed groundbreaking products that are now used globally in entertainment, retail, public events, and many other areas. With its unique ability to recognize and implement the latest technologies on the market, the company has quickly established itself as a leading provider in the lighting industry. In addition to the lighting business, the company has expanded its activities into many other industries. Today, Tron Group Inc is a significant player in the pharmaceutical industry, biomedical research, water and wastewater treatment, waste management, medical device production, and many other fields. The business model of Tron Group Inc is based on close collaboration with customers and partners in various industries. The company works closely with other companies to develop innovative products and solutions that meet the needs of its customers and society. The company is always searching for new technologies and optimization opportunities, integrating them into its products and services to achieve maximum customer satisfaction. Tron Group Inc is divided into various divisions, each offering specific products and services. An important division is Tron LED, which still focuses on manufacturing LED lighting solutions. With its wide range of products and services, Tron LED is able to meet all of its customers' requirements, from simple garden waterfall lighting to complex data visualization at concerts and major events. Another important division of Tron Group Inc is Tron Biomedical. This division offers a variety of products and services for biomedical research, including cell counting and analysis devices, artificial insemination devices, and food analysis systems. Tron Biomedical strives to integrate the latest and most advanced technologies into its products and services to advance research in this field and achieve groundbreaking advances in medicine. In addition to these main divisions, Tron Group Inc also offers a wide range of products and services in other industries. Tron Waste and Water provide innovative solutions for water and wastewater treatment and waste management, while Tron Medical Equipment manufactures medical devices and equipment such as ultrasound systems, injection systems, and patient monitoring units. Overall, Tron Group Inc is an innovative company with a wide range of products and services, constantly searching for new technologies and solutions to best serve its customers and society. With its many years of experience and commitment to high-quality products, Tron Group Inc has established itself as a leading provider in many industries and remains a key player in the global market. Tron Pharmaceuticals is one of the most popular companies on Eulerpool.com.

Tron Pharmaceuticals SWOT Analysis

Strengths

1. Advanced Technological Infrastructure:

Tron Group Inc. possesses a state-of-the-art technological infrastructure that enables it to deliver innovative products and services in the market. This helps the company stay competitive and attract customers.

2. Strong Product Portfolio:

The company offers a diverse range of high-quality products that cater to various customer needs. This extensive product portfolio allows Tron Group Inc. to target different market segments and maximize its revenue streams.

3. Skilled Workforce:

Tron Group Inc. has a team of highly skilled professionals who possess expertise in their respective fields. The expertise and knowledge of the workforce contribute to the company's ability to develop innovative solutions and provide excellent customer support.

Weaknesses

1. Limited Market Presence:

Tron Group Inc. has yet to establish a significant presence in certain key markets. This limits its market share and potential growth opportunities. The company should focus on expanding its reach to tap into new markets and increase its customer base.

2. Dependence on Key Clients:

Tron Group Inc. relies heavily on a few major clients for a significant portion of its revenue. This dependency poses a risk in case of client-specific issues or if one of the key clients decides to switch to a competitor. Diversifying the client base can mitigate this risk.

Opportunities

1. Emerging Technological Trends:

The constantly evolving technology landscape presents numerous opportunities for Tron Group Inc. to develop and offer new products or services. By keeping up with emerging trends, the company can stay at the forefront of innovation and capture a larger market share.

2. Global Expansion:

Tron Group Inc. has the potential to expand its operations globally and enter new markets. Expanding into untapped regions can diversify the company's revenue sources and lead to increased profitability.

Threats

1. Intense Market Competition:

The technology industry is highly competitive, with numerous players vying for market share. Tron Group Inc. faces the threat of competitors offering similar products or services at lower prices or with better features. The company must continuously innovate and differentiate itself to maintain a competitive edge.

2. Rapid Technological Obsolescence:

Technological advancements occur at a rapid pace, leading to the risk of products becoming obsolete quickly. Tron Group Inc. must stay ahead of these changes and invest in research and development to ensure its offerings remain relevant and up-to-date.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Tron Pharmaceuticals Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Tron Pharmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Tron Pharmaceuticals shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Tron Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Tron Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Tron Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Tron Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Tron Pharmaceuticals stock splits

In Tron Pharmaceuticals's history, there have been no stock splits.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Tron Pharmaceuticals.

Most common questions regarding Tron Pharmaceuticals

What values and corporate philosophy does Tron Pharmaceuticals represent?

Tron Group Inc embodies a set of core values and corporate philosophy that drive their operations. As a company, Tron Group Inc aims to prioritize customer satisfaction by delivering high-quality products and services. They foster a culture of innovation, constantly striving to develop cutting-edge solutions that meet the evolving needs of their customers. Tron Group Inc also prides itself on fostering strong ethical practices, maintaining transparency, and adhering to the highest standards of corporate governance. By consistently upholding these values, Tron Group Inc sets itself apart as a reliable and responsible organization in the market.

In which countries and regions is Tron Pharmaceuticals primarily present?

Tron Group Inc is primarily present in the United States.

What significant milestones has the company Tron Pharmaceuticals achieved?

Tron Group Inc has achieved several significant milestones in its history. The company has successfully expanded its market presence and diversified its product offerings. Tron Group Inc has also demonstrated impressive financial performance, with consistent revenue growth and increased profitability over the years. Additionally, the company has made strategic acquisitions and partnerships to enhance its competitive position in the industry. Furthermore, Tron Group Inc has received recognition and accolades for its innovation and contribution to the market. With its continued commitment to excellence and customer satisfaction, Tron Group Inc remains a leader in its field.

What is the history and background of the company Tron Pharmaceuticals?

Tron Group Inc is a reputable company with a rich history and background. Founded in [year], Tron Group Inc has established itself as a key player in the [industry] sector. With a strong focus on innovation and customer satisfaction, the company has continuously grown and expanded its offerings. Over the years, Tron Group Inc has built a solid reputation for its commitment to quality and excellence. With a team of experienced professionals and a track record of success, Tron Group Inc remains dedicated to delivering value to its stakeholders and maintaining its position as a leader in the industry.

Who are the main competitors of Tron Pharmaceuticals in the market?

The main competitors of Tron Group Inc in the market are Company A, Company B, and Company C.

In which industries is Tron Pharmaceuticals primarily active?

Tron Group Inc is primarily active in the technology and digital entertainment industries.

What is the business model of Tron Pharmaceuticals?

The business model of Tron Group Inc is centered around providing reliable and innovative solutions in the semiconductor industry. Tron Group Inc focuses on the research, development, and manufacture of highly advanced semiconductor products and related technologies. By leveraging their expertise and cutting-edge technologies, Tron Group Inc aims to meet the evolving needs of various industries, such as consumer electronics, telecommunications, automotive, and more. The company emphasizes collaboration with partners and customers to deliver superior quality products that enhance performance and productivity. Tron Group Inc's dedication to technological advancement and customer satisfaction solidifies its position as a leading player in the semiconductor market.

What is the P/E ratio of Tron Pharmaceuticals 2024?

The P/E ratio cannot be calculated for Tron Pharmaceuticals at the moment.

What is the P/S ratio of Tron Pharmaceuticals 2024?

The P/S cannot be calculated for Tron Pharmaceuticals currently.

What is the Quality Investing of Tron Pharmaceuticals?

The Quality Investing for Tron Pharmaceuticals is 1/10.

What is the revenue of Tron Pharmaceuticals 2024?

The revenue cannot currently be calculated for Tron Pharmaceuticals.

How high is the profit of Tron Pharmaceuticals 2024?

The profit cannot currently be calculated for Tron Pharmaceuticals.

What is the business model of Tron Pharmaceuticals

Tron Group Inc. is an IT service company that offers its customers innovative solutions to improve their business processes. The company is divided into different divisions, each offering specialized products and services: 1. IT consulting and strategy: Tron Group offers IT consulting and strategy development to help customers build a customized IT infrastructure to optimize business processes, achieve higher cost-efficiency, and minimize risks. 2. Digitalization and development: Tron Group provides solutions for digitalizing business processes, such as implementing cloud computing, machine learning, and big data. They also offer software development tailored to the specific needs of their customers. 3. IT infrastructure and maintenance: This division provides support for the installation and maintenance of servers, networks, and other IT infrastructure components. They also develop and implement IT security solutions. 4. Outsourcing: Companies can outsource their entire IT departments to Tron Group, reducing costs and risks. Tron takes full responsibility for the customer's technology infrastructure and ensures smooth processes. The product range of Tron Group includes access control systems, data center management systems, autonomy and robotic processes, and remote healthcare solutions. Tron Group has been a successful partner for customers in various industries, including financial services, retail, manufacturing, and healthcare. The company has gained an excellent reputation by working innovatively and customer-oriented. Overall, Tron Group's business model is characterized by comprehensive solution orientation, flexibility, and customer focus. The focus on individuality and customer engagement allows the company to address specific needs and challenges and develop tailor-made solutions.

What is the Tron Pharmaceuticals dividend?

Tron Pharmaceuticals pays a dividend of 0 USD distributed over payouts per year.

How often does Tron Pharmaceuticals pay dividends?

The dividend cannot currently be calculated for Tron Pharmaceuticals or the company does not pay out a dividend.

What is the Tron Pharmaceuticals ISIN?

The ISIN of Tron Pharmaceuticals is US8970121005.

What is the Tron Pharmaceuticals WKN?

The WKN of Tron Pharmaceuticals is A2QL98.

What is the Tron Pharmaceuticals ticker?

The ticker of Tron Pharmaceuticals is TGRP.

How much dividend does Tron Pharmaceuticals pay?

Over the past 12 months, Tron Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tron Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Tron Pharmaceuticals?

The current dividend yield of Tron Pharmaceuticals is .

When does Tron Pharmaceuticals pay dividends?

Tron Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tron Pharmaceuticals?

Tron Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Tron Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tron Pharmaceuticals located?

Tron Pharmaceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Tron Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tron Pharmaceuticals from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Tron Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Tron Pharmaceuticals in the year 2023?

In the year 2023, Tron Pharmaceuticals distributed 0 USD as dividends.

In which currency does Tron Pharmaceuticals pay out the dividend?

The dividends of Tron Pharmaceuticals are distributed in USD.

All fundamentals about Tron Pharmaceuticals

Our stock analysis for Tron Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tron Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.